Carolyn Dicus Brookes1, Timothy A Turvey2, Ceib Phillips3, Vincent Kopp4, Jay A Anderson5. 1. Chief Resident, Department of Oral and Maxillofacial Surgery, University of North Carolina-Chapel Hill, Chapel Hill, NC. 2. Professor and Chairman, Department of Oral and Maxillofacial Surgery, University of North Carolina-Chapel Hill, Chapel Hill, NC. 3. Professor, Department of Orthodontics, University of North Carolina-Chapel Hill, Chapel Hill, NC. 4. Professor, Department of Anesthesiology, University of North Carolina-Chapel Hill, Chapel Hill, NC. 5. Associate Professor, Departments of Anesthesiology and Oral and Maxillofacial Surgery, University of North Carolina-Chapel Hill, Chapel Hill, NC. Electronic address: janderson@aims.unc.edu.
Abstract
PURPOSE: To assess the prevalence of postdischarge nausea and vomiting (PDNV) after Le Fort I osteotomy with and without the use of a multimodal antiemetic protocol shown to decrease postoperative nausea and vomiting (PONV). MATERIALS AND METHODS: Consecutive patients undergoing Le Fort I osteotomy with or without additional procedures at a single academic institution formed the intervention cohort for an institutional review board-approved prospective clinical trial with a retrospective comparison group. The intervention cohort was managed with a multimodal antiemetic protocol. The comparison group consisted of consecutive patients who underwent similar surgical procedures at the same institution before protocol implementation. All patients were asked to complete a postdischarge diary documenting the occurrence of nausea and vomiting. Those who completed the diaries were included in this analysis. Data were analyzed with the Fisher exact test and the Wilcoxon rank sum test. A P value less than .05 was considered significant. RESULTS: Diaries were completed by 85% of patients in the intervention group (79 of 93) and 75% of patients in the comparison group (103 of 137). Patients in the intervention (n = 79) and comparison (n = 103) groups were similar in the proportion of patients with validated risk factors for PDNV, including female gender, history of PONV, age younger than 50 years, opioid use in the postanesthesia care unit (PACU), and nausea in the PACU (P = .37). The prevalence of PDNV was unaffected by the antiemetic protocol. After discharge, nausea was reported by 72% of patients in the intervention group and 60% of patients in the comparison group (P = .13) and vomiting was reported by 22% of patients in the intervention group and 29% of patients in the comparison group (P = .40). CONCLUSION: Modalities that successfully address PONV after Le Fort I osteotomy might fail to affect PDNV, which is prevalent in this population. Future investigation will focus on methods to minimize PDNV.
PURPOSE: To assess the prevalence of postdischarge nausea and vomiting (PDNV) after Le Fort I osteotomy with and without the use of a multimodal antiemetic protocol shown to decrease postoperative nausea and vomiting (PONV). MATERIALS AND METHODS: Consecutive patients undergoing Le Fort I osteotomy with or without additional procedures at a single academic institution formed the intervention cohort for an institutional review board-approved prospective clinical trial with a retrospective comparison group. The intervention cohort was managed with a multimodal antiemetic protocol. The comparison group consisted of consecutive patients who underwent similar surgical procedures at the same institution before protocol implementation. All patients were asked to complete a postdischarge diary documenting the occurrence of nausea and vomiting. Those who completed the diaries were included in this analysis. Data were analyzed with the Fisher exact test and the Wilcoxon rank sum test. A P value less than .05 was considered significant. RESULTS: Diaries were completed by 85% of patients in the intervention group (79 of 93) and 75% of patients in the comparison group (103 of 137). Patients in the intervention (n = 79) and comparison (n = 103) groups were similar in the proportion of patients with validated risk factors for PDNV, including female gender, history of PONV, age younger than 50 years, opioid use in the postanesthesia care unit (PACU), and nausea in the PACU (P = .37). The prevalence of PDNV was unaffected by the antiemetic protocol. After discharge, nausea was reported by 72% of patients in the intervention group and 60% of patients in the comparison group (P = .13) and vomiting was reported by 22% of patients in the intervention group and 29% of patients in the comparison group (P = .40). CONCLUSION: Modalities that successfully address PONV after Le Fort I osteotomy might fail to affect PDNV, which is prevalent in this population. Future investigation will focus on methods to minimize PDNV.
Authors: Guzin Gonullu; Sabri Demircan; Mustafa Kemal Demirag; Dilek Erdem; Idris Yucel Journal: Support Care Cancer Date: 2011-07-20 Impact factor: 3.603
Authors: Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair Journal: Ann Intern Med Date: 2010-01-19 Impact factor: 25.391
Authors: René Fernando Rodriguez; Javier Mauricio Castillo; Maria Del Pilar Castillo; Paola Daza Nuñez; Mario Fernando Rodriguez; José Manuel Restrepo; Jorge Martin Rodriguez; Yamileth Ortiz; Ana Maria Angel Journal: Clin Ther Date: 2007-04 Impact factor: 3.393
Authors: Jennifer Holder-Murray; Stephen A Esper; Michael L Boisen; Julie Gealey; Katie Meister; David S Medich; Kathirvel Subramaniam Journal: Korean J Anesthesiol Date: 2019-05-17
Authors: Alberto A Uribe; Tristan E Weaver; Marco Echeverria-Villalobos; Luis Periel; Joshua Pasek; Juan Fiorda-Diaz; Marilly Palettas; Roman J Skoracki; Stephen J Poteet; Jarrett A Heard Journal: Front Med (Lausanne) Date: 2022-08-15